2021 ASCO Annual Meeting Auditors All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Expert Testimony Travel, Other Relationship (OPTIONAL) (OPTIONAL) Open Ownership Interests Role Other Intellectual Accommodations, Uncompensated Payments Link Property Expenses Relationships Patrick Burke Lilly (I), Eisai (I) Novartis (Inst), Takeda (Inst) Sham Mailankody Physician Education Juno Therapeutics (Inst), Resource, Plexus Takeda (Inst), Janssen Oncology (Inst), Allogene (Inst), Bristol-Myers Squibb (Inst) Lisa Law Mary Cianfrocca Roche/Genentech Roche/Genentech Brian O'Sullivan IBA, Merck, Pfizer Erica Stringer-Reasor Breast Cancer Index, Lilly, Immunomedics, Novartis, Lilly Susan G. Komen for the Cascadian Therapeutics, Genentech https://openpayments Mylan Lilly, OncoSec Cure, V Foundation Lilly data.cms.gov/physician /974630 Rodabe Amaria Iovance Biotherapeutics, Merck (Inst), Bristol-Myers Nektar, Novartis Squibb (Inst), Novartis (Inst), Array BioPharma (Inst), Genentech (Inst), Iovance Biotherapeutics (Inst) Julia White Intraop Medical (Inst) Fabrice Andre Pegacsy AstraZeneca (Inst), Novartis, Roche, Novartis (Inst), Pfizer GlaxoSmithKline, (Inst), Lilly (Inst), Roche AstraZeneca (Inst), Daiichi (Inst) Kunal Kadakia Kathleen Moore Research To Practice, Genentech/Roche, PTC Therapeutics (Inst), Prime Oncology, Physician Immunogen, AstraZeneca Lilly (Inst), Merck (Inst), Education Resource (Inst), Tesaro (Inst), VBL Tesaro (Inst), Genentech Therapeutics, Merck, (Inst), Clovis Oncology Aravive, Pfizer/EMD (Inst), Lilly Foundation Serono, Eisai, Abbvie, (Inst), Regeneron (Inst), Vavotar, Mersana (Inst), Advaxis (Inst), Bristol- Myriad Genetics Myers Squibb (Inst), Verastem (Inst), Novartis Pharmaceuticals UK (Inst), AstraZeneca (Inst), Agenus (Inst), Takeda (Inst), Forty Seven (Inst), Immunogen (Inst), Bayer (Inst), Novogen (Inst), Abbvie/Stemcentrx (Inst) Leslie Ballas University of Southern California Keck School of Medicine Benedito Carneiro Tempus, EMD Serono, Abbvie (Inst), Pfizer (Inst), Foundation Medicine Bayer (Inst), AstraZeneca/ MedImmune (Inst), Astellas Pharma (Inst), Actuate Therapeutics (Inst) Walid Shaib Ipsen, Lexicon, Bristol- ArQule (Inst), Lilly (Inst), Lexicon Myers Squibb, Blueprint Basilea (Inst), Lexicon Medicines, Natter, Mylan (Inst) Ishmael Jaiyesimi Edgardo Santos Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, Merck, Novartis, AstraZeneca, Takeda, Sanofi Genzyme, Lilly, Astellas Pharma, G1 Therapeutics Ryan Gentzler Jimmy Ruiz AstraZeneca AstraZeneca, Genentech AstraZeneca (Inst), Roche AstraZeneca, (Inst), BeyondSpring Genentech/Roche Pharmaceuticals (Inst), ER Squibb Andrew McKenzie Andrew Seidman Genomic Health, Eisai, Genentech/Roche, Eisai, Genomic Health, Eisai, Bayer, Odonate Lilly, Genentech/Roche, Novartis, Lilly, Odonate Genentech/Roche, Lilly, Therapeutics (Inst), Nektar Novartis, AstraZeneca, Therapeutics, Novartis/Pfizer, (Inst) Immunomedics BeyondSpring Genentech/Roche, Pharmaceuticals, Pfizer, AstraZeneca/ MedImmune Immunomedics Don Dizon InfiniteMD, NeuHope i-Mab, Clovis Oncology, Merck Sharp & Dohme https://openpayments AstraZeneca, Regeneron, (Inst), Bristol-Myers data.cms.gov/physician Tesaro Squibb (Inst), Kazia Pharmaceuticals (Inst), /744193/summary Tesaro (Inst) Emily Slotkin Eli Lilly and Company (Inst) Ignacio Garrido-Laguna Array BioPharma, Eisai Novartis (Inst), Ignyta (Inst), Halozyme (Inst), Bayer (Inst), Bristol-Myers Squibb (Inst), Pfizer (Inst), MedImmune (Inst), Lilly (Inst), Incyte (Inst), GlaxoSmithKline (Inst), ARMO BioSciences (Inst), Tolero Pharmaceuticals (Inst), BridgeBio Pharma (Inst), Jacobio (Inst) Saad Usmani Celgene, Amgen, Janssen Celgene, Takeda, Amgen, Celgene, Array Oncology, Seattle Janssen Oncology, Sanofi BioPharma, Janssen Genetics, Takeda, Oncology, Pharmacyclics, GlaxoSmithKline, Sanofi, Bristol-Myers Karyopharm Therapeutics, Squibb, Amgen, Seattle Abbvie, SkylineDX, Merck, Genetics, Merck, Skyline Oncopeptides Diagnostics, GlaxoSmithKline Shilpa Gupta Nektar AstraZeneca, Exelixis, Bristol-Myers Squibb, Merck, Pfizer, Bristol- Bristol-Myers Squibb, Janssen Oncology, Myers Squibb, Seattle Merck Sharp & Dohme, Exelixis Genetics Seattle Genetics Rachel Grisham Mateon Therapeutics, Context Therapeutics EMD Serono Prime Oncology, MCM Verastem Clovis Oncology, (Inst) Education, OncLive, Regeneron, Aptiude Health GlaxoSmithKline Dax Kurbegov HCA Healthcare Bristol-Myers Squibb Novartis, Seattle Genetics, Varian Medical Systems, Lilly Amanda Walker AstraZeneca, Reflexion AstraZeneca Medical, RadImmune Simon Lo Elekta (Inst) Gregory Cote PharmaMar, Epizyme, C4 Macrogenics (Inst), PharmaMar Therapeutics Boston Biomedical (Inst), PharmaMar (Inst), Epizyme (Inst), Agios (Inst), Eisai (Inst), Merck KGaA (Inst), Plexxikon (Inst), CBA (Inst), Bavarian Nordic, Bayer (Inst), Springworks Therapeutics (Inst) Ajay Nooka Amgen, Janssen Amgen (Inst), Janssen GlaxoSmithKline Oncology, Celgene, Bristol- Oncology (Inst), Takeda Myers Squibb, (Inst) GlaxoSmithKline, Takeda, Oncopeptides, Karyopharm Therapeutics, Adaptive Biotechnologies, Genzyme Mohamed Salem Taiho Pharmaceutical, Genentech/Roche, Taiho Exelixis, Bristol-Myers Pharmaceutical Squibb Marina Garassino MSD Oncology, Bristol-Myers Squibb, AstraZeneca, Takeda, Bristol-Myers Squibb Pfizer, Roche, AstraZeneca/ MSD, AstraZeneca, MSD Oncology, Celgene, (Inst), MSD (Inst), AstraZeneca MedImmune, Novartis, Takeda, Roche, Incyte, Roche, Bristol- Roche/Genentech (Inst), GlaxoSmithKline, Takeda, Tiziana Life Sciences, Myers Squibb, Otsuka, Eli AstraZeneca/ MedImmune Roche, Bristol-Myers Sanofi/Aventis, Celgene, Lilly (Inst), AstraZeneca (Inst), Squibb Daiichi Sankyo, Inivata, Pfizer (Inst), Incyte, Pfizer, Seattle GlaxoSmithKline (Inst), Genetics, Eli Lilly, Novartis (Inst), Merck GlaxoSmithKline, Bayer (Inst), Incyte (Inst), Takeda Healthcare (Inst), Spectrum Pharmaceuticals, Blueprint Pharmaceuticals (Inst), Medicines, Janssen, Blueprint Medicines (Inst), Regeneron Eli Lilly (Inst), Ipsen (Inst), Janssen (Inst), Exelixis (Inst), MedImmune (Inst), Sanofi (Inst), Pfizer (Inst), Amgen (Inst) Michael Sabel Watermark Research Breast Cancer Ally and Partners Melanoma Ally mobile technologies Edward Garon Dracen, EMD Serono, Merck (Inst), Genentech Novartis, GlaxoSmithKline, (Inst), AstraZeneca (Inst), Merck, Boehringer Novartis (Inst), Lilly (Inst), Ingelheim, Shionogi, Eisai, Bristol-Myers Squibb Bristol-Myers Squibb, ABL (Inst), Mirati Therapeutics Bio, Sanofi, Xilio (Inst), Dynavax (Inst), Iovance Biotherapeutics (Inst), Neon Therapeutics (Inst), EMD Serono (Inst) Mairead McNamara Novartis Ipsen, Shire, Sirtex NuCana BioMed NuCana BioMed, Ipsen, Bayer, Novartis Medical, Incyte Servier Bradley Carthon Eisai, Bristol-Myers Squibb Alkermes (Inst), Bristol-Myers Squibb Foundation, MedImmune (Inst), Merck Immunomedics (Inst) Suparna Wedam Joanne Jeter Pfizer, Array BioPharma Merck, Bristol-Myers Pfizer, Array BioPharma Squibb (Inst) Shadia Jalal Adaptimmune AstraZeneca/ MedImmune, Tesaro, Astex Pharmaceuticals Milos Miljkovic Maura Gillison Bristol-Myers Squibb, Bristol-Myers Squibb Merck, EMD Serono, (Inst), Genocea Roche, Kura, BioNTech, Biosciences (Inst), Shattuck, Bayer, Cullinan (Inst) Debiopharm Group, Ipsen, Gilead Sciences, Bicara Therapeutics, BioNTech AG Ezra Cohen Bayer, MSD, Merck, Regeneron, BioNTech, Eisai, Gilead Gina D'Amato Blueprint Medicines, Epiz, Deciphera, Daiichi Sankyo/Lilly Efrat Dotan Pfizer, Boston Medical ARMO BioSciences Pfizer (Inst), Bayer (Inst), Incyte (Inst), Boston Biomedical (Inst), Merck (Inst), MedImmune (Inst), GlaxoSmithKline (Inst), Lilly (Inst), AstraZeneca (Inst) Ramon Andrade de Mello AstraZeneca, Novartis, Pfizer, Zodiac, MSD AstraZeneca Amgen, Roche, Merck, Astellas Pharma, Merck Oncology Pierre Fabre, Serono, Eurofarma AstraZeneca, Bristol- Myers Squibb Brazil, Astellas Pharma William Kelly Janssen Oncology, Bayer Merck Sharp & Dohme Sanofi (Inst), Novartis Janssen Oncology, Merck (Inst), Janssen Oncology Sharp & Dohme (Inst), Bayer (Inst), Exelixis (Inst), Seattle Genetics (Inst), Endocyte (Inst), Amgen (Inst), BioClin Therapeutics (Inst), Sarah Cannon Research Institute (Inst), Hoffman-LaRoche (Inst) James Cleary Bristol-Myers Squibb Merck, Tesaro, Roche, Agios, Bristol- AstraZeneca, Esperas Myers Squibb Pharma, Abbvie (Inst), Merus (Inst), Roche/Genentech (Inst), Bristol-Myers Squibb (Inst) Cathy Eng Foundation Medicine, Natera, GlaxoSmithKline, Gilead/Forty Seven, Incyte, Mirati Therapeutics Jeremy Cetnar Gretchen Kimmick Boehringer Ingelheim, Eisai Roche (Inst), Genentech Royalties for Seattle Genetics, Novartis, Eisai, Genomic Health, (Inst), Abraxis BioScience CardioOncology textbook Foundation Medicine Agendia (Inst), Bristol-Myers from Springer, UpToDate Squibb (Inst), Puma Royalties Biotechnology (Inst), Wyeth (Inst), Novartis (Inst), GlaxoSmithKline (Inst), Johnson & Johnson (Inst), Pfizer (Inst) Ulka Vaishampayan Pfizer, Exelixis, Bayer, Pfizer, Bayer, Exelixis Astellas Pharma, Exelixis, Bristol-Myers Bristol-Myers Squibb, Squibb/Medarex, Merck Merck KGaA Serono, Advanced Accelerator Application, Alkermes, Helsinn Therapeutics Nina J. Karlin Thomas George Tempus Bristol-Myers Squibb https://openpayments (Inst), Merck (Inst), data.cms.gov/physician AstraZeneca/ MedImmune (Inst), Lilly (Inst), Bayer /321938/summary (Inst), Incyte (Inst),